查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年亚太地区肠外营养市场预测 - 区域分析 - 按营养素类型和最终用户
市场调查报告书
商品编码
1562404

2030 年亚太地区肠外营养市场预测 - 区域分析 - 按营养素类型和最终用户

Asia Pacific Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User
出版日期: | 出版商: The Insight Partners | 英文 95 Pages | 订单完成后即时交付

价格

2022年亚太肠外营养市场价值为8.6159亿美元，预计2030年将达到14.7133亿美元；预计2022年至2030年复合年增长率为6.9%。

公司新产品开发推动亚太肠外营养市场

肠外医疗营养市场的公司不断关注新产品的推出，这有助于他们提高销售额。以下提到了肠外营养市场的一些值得注意的发展：

2023年，百特韩国推出了Olimel N12E，这是一种富含蛋白质的全肠外营养（TPN）液，适用于重症患者。

2023年，JW Holdings开始透过当地製药公司AsiaPharma LLC向蒙古大规模出口三腔全肠外营养（TPN）Winuf Central 736/1,085ml。

因此，营养新产品的开发预计将为预测期内的市场成长创造机会。

亚太地区肠外营养市场概况

由于幽门螺旋桿菌感染率不断上升，中国面临较高的胃癌负担。世界卫生组织国际癌症研究机构（IARC）及英国和中国合作机构的一项研究（2021）发现，幽门螺旋桿菌感染在中国很普遍。此外，幽门螺旋桿菌感染是30岁以上成年人62.1%的贲门型胃癌病例和78.5%的非贲门型胃癌病例的主要原因。 IARC的这项研究估计，中国每年约有34万例因幽门螺旋桿菌感染引起的胃癌病例。根据2020年10月发布的全球疾病负担资料，胃癌是2019年十大死亡原因之一。万，粗发病率为33.06。根据同一来源，估计 2020 年男女新发病例数（0-74 岁）为 478,508 例。因此，由于上述因素，预测期内中国肠外营养市场可能会显着成长。

亚太地区肠外营养市场收入及 2030 年预测（百万美元）

亚太地区肠外营养市场区隔

亚太肠外营养市场根据营养素类型、最终用户和国家进行细分。根据营养素类型，亚太地区肠外营养市场分为单剂量胺基酸溶液、肠外脂肪乳、碳水化合物、微量元素以及维生素和矿物质。 2022 年，单剂量胺基酸溶液细分市场占据最大市场份额。

依最终用户划分，亚太肠外营养市场分为医院、诊所等。 2022 年，医院细分市场占据最大市场份额。

依国家划分，亚太肠外营养市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2022年，中国在亚太肠外营养市场占有率中占据主导地位。

ICU Medical Inc、Grifols SA、辉瑞公司、大冢製药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd、四川科伦生物製药有限公司和Vifor Pharma Management AG 是一些领先的公司在亚太肠外营养市场营运的参与者。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区肠外营养市场 - 主要产业动态

  • 市场驱动因素
    • 胃肠道疾病盛行率上升
    • 营养不良和早产病例激增
  • 市场限制
    • 与肠外餵食系统相关的机械、胃肠道和代谢併发症
  • 市场机会
    • 公司新产品开发
  • 未来趋势
    • 营养产品配方创新
  • 影响分析

第 5 章：肠外营养市场 - 亚太市场分析

  • 概述
  • 肠外营养市场收入，2020 - 2030

第 6 章：亚太地区肠外营养市场分析 - 按营养类型

  • 概述
  • 单剂量氨基酸溶液
  • 肠外脂质乳剂
  • 碳水化合物
  • 微量元素
  • 维生素和矿物质

第 7 章：亚太地区肠外营养市场分析 - 依最终用户

  • 概述
  • 医院
  • 诊所
  • 其他的

第 8 章：亚太地区肠外营养市场 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 9 章：产业格局

  • 概述
    • 概述

第 10 章：公司简介

  • ICU Medical Inc
  • Grifols SA
  • Pfizer Inc
  • Otsuka Pharmaceuticals Co Ltd
  • Baxter International Inc
  • B Braun SE
  • Fresenius Kabi AG
  • Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
  • Vifor Pharma Management AG
  • Aculife Healthcare Pvt Ltd

第 11 章：附录

Product Code: BMIRE00030378

The Asia Pacific parenteral nutrition market was valued at US$ 861.59 million in 2022 and is expected to reach US$ 1,471.33 million by 2030; it is estimated to record a CAGR of 6.9% from 2022 to 2030.

New Product Developments by Companies Boost Asia Pacific Parenteral Nutrition Market

Companies operating in the parenteral medical nutrition market constantly focus on new product launches, which help them improve their sales. A few of the noteworthy developments in the parenteral nutrition market are mentioned below:

In 2023, Baxter Korea launched Olimel N12E, a protein-rich Total Parenteral Nutrition (TPN) fluid for critically ill patients.

In 2023, JW Holdings started exporting Winuf Central 736/1,085ml, a three-chamber total parenteral nutrition (TPN), on a large scale to Mongolia via AsiaPharma LLC, a local pharmaceutical company.

Thus, new product development of nutrition is anticipated to create opportunities for the market growth during the forecast period.

Asia Pacific Parenteral Nutrition Market Overview

China faces a high burden of stomach cancer due to the growing prevalence of H. pylori infection among the people. A study (2021) by the World Health Organization's International Agency for Research on Cancer (IARC) and partner institutions in the UK and China found that H. pylori infection is prevalent in China. Furthermore, H. pylori infection was the prime cause for 62.1% of cardia gastric cancer cases and 78.5% of non-cardia gastric cancer cases among adults over 30 years of age. This study by IARC estimated that ~340,000 cases of gastric cancer due to H. pylori infection occur in China every year. According to Global Burden of Diseases study published in October 2020, stomach cancer was among the top 10 causes of death in 2019. Similarly, according to the latest data from the International Agency for Research on Cancer (IARC), the estimated age-standardized incidence rate for stomach cancer in China is 20.58 per 100,000, and the crude rate is 33.06. As per the same source, the estimated number of new cases (aged 0-74) in 2020 for both sexes was 478,508. Thus, owing to the abovementioned factors, the market for parenteral nutrition is likely to witness remarkable growth in China during the forecast period.

Asia Pacific Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Parenteral Nutrition Market Segmentation

The Asia Pacific parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Asia Pacific parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the Asia Pacific parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific parenteral nutrition market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Asia Pacific parenteral nutrition market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Parenteral Nutrition Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 4.1.2 Surge in Cases of Malnutrition and Premature Births
  • 4.2 Market Restraints
    • 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
  • 4.3 Market Opportunities
    • 4.3.1 New Product Developments by Companies
  • 4.4 Future Trends
    • 4.4.1 Innovation in Formulations of Nutrition Products
  • 4.5 Impact Analysis

5. Parenteral Nutrition Market - Asia Pacific Market Analysis

  • 5.1 Overview
  • 5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Asia Pacific Parenteral Nutrition Market Analysis - by Nutrient Type

  • 6.1 Overview
  • 6.2 Single Dose Amino Acid Solution
    • 6.2.1 Overview
    • 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Parenteral Lipid Emulsion
    • 6.3.1 Overview
    • 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Carbohydrates
    • 6.4.1 Overview
    • 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Trace Elements
    • 6.5.1 Overview
    • 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Vitamins and Minerals
    • 6.6.1 Overview
    • 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Parenteral Nutrition Market Analysis - by End User

  • 7.1 Overview
  • 7.2 Hospitals
    • 7.2.1 Overview
    • 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Clinics
    • 7.3.1 Overview
    • 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Parenteral Nutrition Market - Country Analysis

  • 8.1 Asia Pacific
    • 8.1.1 Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
      • 8.1.1.1 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.1.1 Overview
        • 8.1.1.1.2 China: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.1.3 China: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.1.4 China: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.2.1 Overview
        • 8.1.1.2.2 Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.2.3 Japan: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.2.4 Japan: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.3 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.3.1 Overview
        • 8.1.1.3.2 India: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.3.3 India: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.3.4 India: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.4 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.4.1 Overview
        • 8.1.1.4.2 Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.4.3 Australia: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.4.4 Australia: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.5 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.5.1 Overview
        • 8.1.1.5.2 South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.5.3 South Korea: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.5.4 South Korea: Parenteral Nutrition Market Breakdown, by End User
      • 8.1.1.6 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.6.1 Overview
        • 8.1.1.6.2 Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
        • 8.1.1.6.3 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by Nutrient Type
        • 8.1.1.6.4 Rest of Asia Pacific: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

  • 9.1 Overview
    • 9.1.1 Overview

10. Company Profiles

  • 10.1 ICU Medical Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Grifols SA
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Pfizer Inc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Otsuka Pharmaceuticals Co Ltd
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Baxter International Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 B Braun SE
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Fresenius Kabi AG
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Vifor Pharma Management AG
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Aculife Healthcare Pvt Ltd
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Parenteral Nutrition Market Segmentation
  • Table 2. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 3. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 4. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 5. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 6. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 7. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 8. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 9. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 10. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 11. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 12. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
  • Table 13. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
  • Table 15. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

  • Figure 1. Parenteral Nutrition Market Segmentation, By Country
  • Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
  • Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
  • Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
  • Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Asia Pacific: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 16. Asia Pacific: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 17. China: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 18. Japan: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 19. India: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 20. Australia: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 21. South Korea: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 22. Rest of Asia Pacific: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)